Red cell perturbations by amyloid beta-protein.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biochimica et Biophysica Acta

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12829257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hydrogen-peroxide-induced heme degradation in red blood cells: the protective roles of catalase and glutathione peroxidase.

  2003cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Alzheimer Disease as a Vascular Disorder: Nosological Evidence

  2002cited by this paper
• Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease.

  2002cited by this paper
• Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease.

  2001cited by this paper
• Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate.

  2001cited by this paper
• Heteropolymer‐mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications

  2001cited by this paper
• Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis

  2001cited by this paper
• Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma.

  2000cited by this paper
• The origin of red cell fluorescence caused by hydrogen peroxide treatment.

  2000cited by this paper
• Hemorheological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer's type: adverse effects on cerebromicrovascular system.

  2000cited by this paper
• Reaction of hydrogen peroxide with ferrylhemoglobin: superoxide production and heme degradation.

  2000cited by this paper
• The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain.

  2000cited by this paper
• Heme degradation during autoxidation of oxyhemoglobin.

  2000cited by this paper
• Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes.

  2000cited by this paper
• Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons

  1999cited by this paper
• Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

  1999cited by this paper
• Lipoprotein‐free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome

  1999cited by this paper
• Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress.

  1999cited by this paper
• Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease.

  1999cited by this paper
• Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets.

  1998cited by this paper
• Maze learning impairment is associated with stress hemopoiesis induced by chronic treatment of aged rats with human recombinant erythropoietin.

  1998cited by this paper
• Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.

  1998cited by this paper
• Kinetic theory of fibrillogenesis of amyloid beta-protein.

  1997cited by this paper
• Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42*

  1997cited by this paper
• Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells.

  1997cited by this paper
• beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease.

  1997cited by this paper
• The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology.

  1997cited by this paper
• The putative blood-brain barrier transporter for the beta-amyloid binding protein apolipoprotein j is saturated at physiological concentrations.

  1997cited by this paper
• Effect of cholesterol content in diet on capillary flow of rat erythrocytes. Part I: Geometric and flow characteristics

  1997cited by this paper
• Alzheimer's soluble amyloid beta is a normal component of human urine.

  1997cited by this paper
• First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro.

  1996cited by this paper
• Proteolytic Processing of Alzheimer's Disease βA4 Amyloid Precursor Protein in Human Platelets (*)

  1995cited by this paper
• Platelets are the primary source of amyloid beta-peptide in human blood.

  1995cited by this paper
• Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death

  1995cited by this paper
• Potency ranking of methemoglobin‐forming agents

  1995cited by this paper
• The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma.

  1994cited by this paper
• Irregular distortion of the erythrocytes (acanthocytes, spur cells) in senile dementia.

  1994cited by this paper
• Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry.

  1994cited by this paper
• A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

  1994cited by this paper
• Hydrogen peroxide mediates amyloid beta protein toxicity.

  1994cited by this paper
• Alzheimer's disease: a molecular perspective

  1994cited by this paper
• Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.

  1993cited by this paper
• The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.

  1993cited by this paper
• Apoptosis is induced by beta-amyloid in cultured central nervous system neurons.

  1993cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer's disease.

  1991cited by this paper
• Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures.

  1991cited by this paper
• Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2+ influx in cultured hippocampal neurons.

  1990cited by this paper
• Molecular genetic approaches to Alzheimer's disease.

  1989cited by this paper
• Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.

  1989cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper

• Hemoglobin in the brain frontal lobe tissue of patients with Alzheimer’s disease is susceptible to reactive nitrogen species-mediated oxidative damage

  2025cites this paper
• Amyloid β Peptide Modifies Membrane Architecture and Surface Electrostatic Properties of Human Red Blood Cells

  2025cites this paper
• Mechanism of oxidative stress and neurotoxicity associated with heme and copper-Aβ relevant to Alzheimer's disease.

  2025cites this paper
• Sphingosine-1-phosphate Decreases Erythrocyte Dysfunction Induced by β-Amyloid

  2024cites this paper
• Structural Conversion of Serotonin into Amyloid-like Nanoassemblies Conceptualizes an Unexplored Neurotoxicity Risk.

  2024cites this paper
• Marine Plasmalogens: A Gift from the Sea with Benefits for Age-Associated Diseases

  2023cites this paper
• The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy

  2022cites this paper
• A Critical Review of the Use of Surfactant-Coated Nanoparticles in Nanomedicine and Food Nanotechnology

  2021cites this paper
• Exercise as Potential Therapeutic Target to Modulate Alzheimer’s Disease Pathology in APOE ε4 Carriers: A Systematic Review

  2021cites this paper
• Apolipoprotein E Polymorphism and Oxidative Stress in Human Peripheral Blood Cells: Can Physical Activity Reactivate the Proteasome System through Epigenetic Mechanisms?

  2020cites this paper
• Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer’s disease: evidences and perspectives

  2020cites this paper
• Activation of tyrosine phosphorylation signaling in erythrocytes of patients with alzheimer's disease.

  2020cites this paper
• DNAzymes as Catalysts for l-Tyrosine and Amyloid β Oxidation

  2020cites this paper
• Detection of Protein Aggregation in Live Plasmodium Parasites

  2020influential citation
• Amyloid β peptide affects erythrocyte morphology: Role of intracellular signaling pathways

  2019cites this paper
• Self-Assembly of Artificial Sweetener Aspartame Yields Amyloid-like Cytotoxic Nanostructures.

  2019cites this paper
• Morphological changes induced in erythrocyte by amyloid beta peptide and glucose depletion: A combined atomic force microscopy and biochemical study.

  2019cites this paper
• Impact of ApoE Polymorphism and Physical Activity on Plasma Antioxidant Capability and Erythrocyte Membranes

  2019cites this paper
• Nix-mediated mitophagy regulates platelet activation and life span.

  2019cites this paper
• Amyloid β and free heme: bloody new insights into the pathogenesis of Alzheimer’s disease

  2018cites this paper
• Free Heme and Amyloid-β: A Fatal Liaison in Alzheimer’s Disease

  2018influential citation
• Intrinsic property of phenylalanine to trigger protein aggregation and hemolysis has a direct relevance to phenylketonuria

  2017cites this paper
• Altered peripheral profile of blood cells in Alzheimer disease

  2017cites this paper
• Docosahexaenoic acid: one molecule diverse functions

  2017cites this paper
• Biochemical signature in Alzheimer’s disease

  2017cites this paper
• Erythrocytes as Potential Link between Diabetes and Alzheimer’s Disease

  2017cites this paper
• Exploring Erythrocytes as Blood Biomarkers for Alzheimer’s Disease

  2017cites this paper
• Methionine 35 sulphoxide reduces toxicity of Aβ in red blood cell

  2017cites this paper
• Vascular dysfunction-associated with Alzheimer’s disease

  2016cites this paper
• Involvement of acetylcholinesterase and protein kinase C in the protective effect of caffeine against β-amyloid-induced alterations in red blood cells.

  2016cites this paper
• Alterations in the Levels of Amyloid-β, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer’s Disease: Possible Interactions between Amyloid-β and These Lipids

  2015cites this paper
• The peripheral blood of Aβ binding RBC as a biomarker for diagnosis of Alzheimer's disease.

  2015cites this paper
• Amyloid beta peptide (1–42)‐mediated antioxidant imbalance is associated with activation of protein kinase C in red blood cells

  2015cites this paper
• Possible roles of amyloids in malaria pathophysiology

  2015cites this paper
• The binding of Aβ1-42 to lipid rafts of RBC is enhanced by dietary docosahexaenoic acid in rats: Implicates to Alzheimer's disease.

  2015cites this paper
• The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin.

  2015cites this paper
• An anemia of Alzheimer's disease

  2014cites this paper
• Biological metals and metal-targeting compounds in major neurodegenerative diseases.

  2014cites this paper
• Studies Targeting α-Glucosidase Inhibition, Antiangiogenic Effects, and Lipid Modification Regulation: Background, Evaluation, and Challenges in the Development of Food Ingredients for Therapeutic Purposes

  2013cites this paper
• Antioxidant status and energy state of erythrocytes in Alzheimer dementia: probing for markers.

  2012cites this paper
• Changes in Phospholipid Composition of Erythrocyte Membrane in Alzheimer's Disease

  2012cites this paper
• Amyloid β Levels in Human Red Blood Cells

  2012cites this paper
• β‐amyloid decreases detectable endothelial nitric oxide synthase in human erythrocytes: a role for membrane acetylcholinesterase

  2012cites this paper
• Amyloid β‐induced erythrocytic damage and its attenuation by carotenoids

  2011cites this paper
• Amyloid β Induces Adhesion of Erythrocytes to Endothelial Cells and Affects Endothelial Viability and Functionality

  2011cites this paper
• Alzheimer’s disease is characterized by more low‐density erythrocytes with increased volume and enhanced β‐amyloid x‐40 content

  2011cites this paper
• Deep-coverage rhesus red blood cell proteome: a first comparison with the human and mouse red blood cell.

  2010cites this paper
• Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrils.

  2009cites this paper
• Electrochemical and Conformational Consequences of Copper (CuI and CuII) Binding to β‐Amyloid(1–40)

  2009cites this paper
• Dual effects of Ginkgo biloba leaf extract on human red blood cells.

  2009cites this paper
• Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.

  2009cites this paper
• Aging, Aluminium and Basal Forebrain Lesions Modify Substrate Kinetics of Erythrocyte Membrane Na,K-ATPase in the Rat

  2008cites this paper
• Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer's disease?

  2008cites this paper
• [The two faces of reactive oxygen species].

  2008cites this paper
• Amyloid toxicity in skeletal myoblasts: Implications for inclusion-body myositis.

  2008cites this paper
• Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's disease.

  2008cites this paper
• Hemoglobin binding to Aβ and HBG2 SNP association suggest a role in Alzheimer's disease

  2008influential citation
• Structural and functional properties of peptides based on the N-terminus of HIV-1 gp41 and the C-terminus of the amyloid-beta protein.

  2008cites this paper
• Serial protein labeling with infrared maleimide dyes to identify cysteine modifications.

  2008cites this paper
• Amyloid peptide inhibits ATP release from human erythrocytes.

  2008cites this paper
• Amyloid Induced Suicidal Erythrocyte Death

  2007cites this paper
• The inflammation-sensitive protein alpha 1-anti-chymotrypsin neutralizes fibrillar aggregation and cytotoxicity of the beta-amyloid peptide more effectively than alpha 1-antitrypsin.

  2007cites this paper
• Amyloid-beta peptide affects the oxygen dependence of erythrocyte metabolism: a role for caspase 3.

  2007cites this paper
• Erythrocyte glycohydrolases in subjects with trisomy 21: could Down's syndrome be a model of accelerated ageing?

  2006cites this paper
• In-depth analysis of the membrane and cytosolic proteome of red blood cells.

  2006cites this paper
• Red cell interactions with amyloid-beta(1-40) fibrils in a murine model.

  2005cites this paper
• Transferrin neutralization of amyloid beta 25-35 cytotoxicity.

  2004cites this paper
• Interactions of Aβ(1–40) with Glycerophosphocholine and Intact Erythrocyte Membranes: Fluorescence and Circular Dichroism Studies

  2004cites this paper
• Influence of beta-amyloid fibrils on the interactions between red blood cells and endothelial cells

  2004cites this paper
• Erythrocyte aging in neurodegenerative disorders.

  2004cites this paper
• Methionine 35 oxidation reduces toxic effects of the amyloid beta-protein fragment (31-35) on human red blood cell.

  2004cites this paper